Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

PURPOSE: We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinblastine, and dacarbazine (ABVD) in a pooled analysis of fo...

Descripción completa

Detalles Bibliográficos
Autores principales: André, Marc P. E., Carde, Patrice, Viviani, Simonetta, Bellei, Monica, Fortpied, Catherine, Hutchings, Martin, Gianni, Alessandro M., Brice, Pauline, Casasnovas, Olivier, Gobbi, Paolo G., Zinzani, Pier Luigi, Dupuis, Jehan, Iannitto, Emilio, Rambaldi, Alessandro, Brière, Josette, Clément‐Filliatre, Laurianne, Heczko, Marian, Valagussa, Pinuccia, Douxfils, Jonathan, Depaus, Julien, Federico, Massimo, Mounier, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520354/
https://www.ncbi.nlm.nih.gov/pubmed/32710498
http://dx.doi.org/10.1002/cam4.3298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520354/
https://www.ncbi.nlm.nih.gov/pubmed/32710498
http://dx.doi.org/10.1002/cam4.3298

Ejemplares similares